Pimaradienoic acid (1) is a
pimarane diterpene (ent-pimara-8(14),15-dien-19-oic acid) extracted at high amounts from various plants including Vigueira arenaria Baker. Compound 1 inhibited
carrageenan-induced paw
edema and
acetic acid-induced abdominal writhing, which are its only known anti-inflammatory activities. Therefore, it is important to further investigate the
analgesic effects of 1.
Oral administration of 1 (1, 3, and 10 mg/kg) inhibited the
acetic acid-induced writhing. This was also observed
at 10 mg/kg via sc and ip routes. Both phases of the
formalin- and complete
Freund's adjuvant (CFA)-induced paw flinch and time spent licking the paw were inhibited by 1. Compound 1 inhibited
carrageenan-, CFA-, and PGE2-induced
mechanical hyperalgesia. Treatment with 1 inhibited
carrageenan-induced production of TNF-α, IL-1β,
IL-33, and
IL-10 and nuclear factor κB activation. Pharmacological inhibitors also demonstrated that the
analgesic effects of 1 depend on activation of the NO-
cyclic GMP-
protein kinase G-
ATP-sensitive potassium channel signaling pathway. Compound 1 did not alter plasma levels of AST, ALT, or
myeloperoxidase activity in the stomach. These results demonstrate that 1 causes
analgesic effects associated with the inhibition of NF-κB activation, reduction of
cytokine production, and activation of the NO-
cyclic GMP-
protein kinase G-
ATP-sensitive potassium channel signaling pathway.